Cargando…

Toxicology of Nanoparticles in Drug Delivery

Nanoparticles have revolutionized biomedicine especially in the field of drug delivery due to their intriguing properties such as systemic stability, level of solubility, and target site specificity. It can, however, be both beneficial and damaging depending on the properties in different environmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Swati, Parveen, Roza, Chatterji, Biswa Prasun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611175/
https://www.ncbi.nlm.nih.gov/pubmed/34840918
http://dx.doi.org/10.1007/s40139-021-00227-z
_version_ 1784603248231972864
author Sharma, Swati
Parveen, Roza
Chatterji, Biswa Prasun
author_facet Sharma, Swati
Parveen, Roza
Chatterji, Biswa Prasun
author_sort Sharma, Swati
collection PubMed
description Nanoparticles have revolutionized biomedicine especially in the field of drug delivery due to their intriguing properties such as systemic stability, level of solubility, and target site specificity. It can, however, be both beneficial and damaging depending on the properties in different environments, thus highlighting the importance of nanotoxicology studies before use in humans. Different types of nanoparticles have been used in drug delivery, and this review summarizes the recent toxicity studies of these nanoparticles. The toxicological evaluation of three widely used nanoparticles in drug delivery that are metal, lipid, and protein nanoparticles has been discussed in detail. Studies have recorded several toxic effects of various nanoparticles such as metal-based nanoparticles have been linked to increased oxidative stress and have the potential to infiltrate the cell nucleus and protein-based nanoparticles have been observed to have hepatotoxicity and nephrotoxicity as their adverse effects. Considering the increasing application of nanoparticles in drug delivery and the growing concerns of regulatory authorities regarding the toxicity of nanocarriers in living organisms, it requires urgent attention to identify the gap in toxicity studies. The review highlights the gap in toxicity studies and potential focus areas to overcome the existing challenges.
format Online
Article
Text
id pubmed-8611175
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-86111752021-11-24 Toxicology of Nanoparticles in Drug Delivery Sharma, Swati Parveen, Roza Chatterji, Biswa Prasun Curr Pathobiol Rep Nanoparticle-Based Drug Delivery (M Gogoi, Section Editor) Nanoparticles have revolutionized biomedicine especially in the field of drug delivery due to their intriguing properties such as systemic stability, level of solubility, and target site specificity. It can, however, be both beneficial and damaging depending on the properties in different environments, thus highlighting the importance of nanotoxicology studies before use in humans. Different types of nanoparticles have been used in drug delivery, and this review summarizes the recent toxicity studies of these nanoparticles. The toxicological evaluation of three widely used nanoparticles in drug delivery that are metal, lipid, and protein nanoparticles has been discussed in detail. Studies have recorded several toxic effects of various nanoparticles such as metal-based nanoparticles have been linked to increased oxidative stress and have the potential to infiltrate the cell nucleus and protein-based nanoparticles have been observed to have hepatotoxicity and nephrotoxicity as their adverse effects. Considering the increasing application of nanoparticles in drug delivery and the growing concerns of regulatory authorities regarding the toxicity of nanocarriers in living organisms, it requires urgent attention to identify the gap in toxicity studies. The review highlights the gap in toxicity studies and potential focus areas to overcome the existing challenges. Springer US 2021-11-24 2021 /pmc/articles/PMC8611175/ /pubmed/34840918 http://dx.doi.org/10.1007/s40139-021-00227-z Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Nanoparticle-Based Drug Delivery (M Gogoi, Section Editor)
Sharma, Swati
Parveen, Roza
Chatterji, Biswa Prasun
Toxicology of Nanoparticles in Drug Delivery
title Toxicology of Nanoparticles in Drug Delivery
title_full Toxicology of Nanoparticles in Drug Delivery
title_fullStr Toxicology of Nanoparticles in Drug Delivery
title_full_unstemmed Toxicology of Nanoparticles in Drug Delivery
title_short Toxicology of Nanoparticles in Drug Delivery
title_sort toxicology of nanoparticles in drug delivery
topic Nanoparticle-Based Drug Delivery (M Gogoi, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611175/
https://www.ncbi.nlm.nih.gov/pubmed/34840918
http://dx.doi.org/10.1007/s40139-021-00227-z
work_keys_str_mv AT sharmaswati toxicologyofnanoparticlesindrugdelivery
AT parveenroza toxicologyofnanoparticlesindrugdelivery
AT chatterjibiswaprasun toxicologyofnanoparticlesindrugdelivery